Endoglin regulates the activation and quiescence of endothelium by participating in canonical and non-canonical TGF-β signaling pathways

Journal of Cell Science

Volumn 126, Issue 6, 2013, Pages 1392-1405

  Park, SunYoung ^a   DiMaio, Terri A ^a   Liu, Wei ^a   Wang, Shoujian ^a   Sorenson, Christine M ^a   Sheibani, Nader ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Angiogenesis; Endothelial cells; Extracellular matrix; MAP kinase pathways; Thrombospondins

Indexed keywords

ENDOGLIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; OXYGEN; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; BRANCHING MORPHOGENESIS; CELL ADHESION; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; HAPLOINSUFFICIENCY; INTRACELLULAR SIGNALING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; RETINA NEOVASCULARIZATION; RETINOPATHY;

ANGIOGENESIS; ENDOTHELIAL CELLS; EXTRACELLULAR MATRIX; MAP KINASE PATHWAYS; THROMBOSPONDINS;

ANIMALS; CELL ADHESION; CELL DIFFERENTIATION; CELL MOVEMENT; ENDOTHELIUM, VASCULAR; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, MUTANT STRAINS; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE SYNTHASE; SEQUENCE DELETION; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84877890780     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.117275     Document Type: Article

References (58)

1. Antonelli-Orlidge, A., Saunders, K. B., Smith, S. R. and D'Amore, P. A. (1989). An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes. Proc. Natl. Acad. Sci. USA 86, 4544-4548.
2. Arthur, H. M., Ure, J., Smith, A. J., Renforth, G., Wilson, D. I., Torsney, E., Charlton, R., Parums, D. V., Jowett, T., Marchuk, D. A. et al. (2000). Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development. Dev. Biol. 217, 42-53.
3. Bernabeu, C., Conley, B. A. and Vary, C. P. (2007). Novel biochemical pathways of endoglin in vascular cell physiology. J. Cell. Biochem. 102, 1375-1388.
4. Bourdeau, A., Dumont, D. J. and Letarte, M. (1999). A murine model of hereditary hemorrhagic telangiectasia. J. Clin. Invest. 104, 1343-1351.
5. Bourdeau, A., Faughnan, M. E. and Letarte, M. (2000). Endoglin-deficient mice, a unique model to study hereditary hemorrhagic telangiectasia. Trends Cardiovasc. Med. 10, 279-285.
6. Carta, L., Smaldone, S., Zilberberg, L., Loch, D., Dietz, H. C., Rifkin, D. B. and Ramirez, F. (2009). p38 MAPK is an early determinant of promiscuous Smad2/3 signaling in the aortas of fibrillin-1 (Fbn1)-null mice. J. Biol. Chem. 284, 5630-5636.
7. Dejana, E., Tournier-Lasserve, E. and Weinstein, B. M. (2009). The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications. Dev. Cell 16, 209-221.
8. Derynck, R. and Zhang, Y. E. (2003). Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425, 577-584.
9. DiMaio, T. A., Wang, S., Huang, Q., Scheef, E. A., Sorenson, C. M. and Sheibani, N. (2008). Attenuation of retinal vascular development and neovascularization in PECAM-1-deficient mice. Dev. Biol. 315, 72-88.
10. Duff, S. E., Li, C., Garland, J. M. and Kumar, S. (2003). CD105 is important for angiogenesis: evidence and potential applications. FASEB J. 17, 984-992.
11. Düwel, A., Eleno, N., Jerkic, M., Arevalo, M., Bolaños, J. P., Bernabeu, C. and López-Novoa, J. M. (2007). Reduced tumor growth and angiogenesis in endoglinhaploinsufficient mice. Tumour Biol. 28, 1-8.
12. Gerber, H. P., McMurtrey, A., Kowalski, J., Yan, M., Keyt, B. A., Dixit, V. and Ferrara, N. (1998). Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 39-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J. Biol. Chem. 273, 30336-30343.
13. Gougos, A. and Letarte, M. (1990). Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells. J. Biol. Chem. 265, 8361-8364.
14. Goumans, M. J., Valdimarsdottir, G., Itoh, S., Lebrin, F., Larsson, J., Mummery, C., Karlsson, S. and ten Dijke, P. (2003). Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling. Mol. Cell 12, 817-828.
15. Hirschi, K. K., Rohovsky, S. A. and D'Amore, P. A. (1998). PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J. Cell Biol. 141, 805-814.
16. Jerkic, M., Rivas-Elena, J. V., Santibanez, J. F., Prieto, M., Rodríguez-Barbero, A., Perez-Barriocanal, F., Pericacho, M., Arévalo, M., Vary, C. P., Letarte, M. et al. (2006a). Endoglin regulates cyclooxygenase-2 expression and activity. Circ. Res. 99, 248-256.
17. Jerkic, M., Rodríguez-Barbero, A., Prieto, M., Toporsian, M., Pericacho, M., Rivas-Elena, J. V., Obreo, J., Wang, A., Pérez-Barriocanal, F., Arévalo, M. et al. (2006b). Reduced angiogenic responses in adult Endoglin heterozygous mice. Cardiovasc. Res. 69, 845-854.
18. Kondo, S., Scheef, E. A., Sheibani, N. and Sorenson, C. M. (2007). PECAM-1 isoform-specific regulation of kidney endothelial cell migration and capillary morphogenesis. Am. J. Physiol. 292, C2070-C2083.
19. Krupinski, J., Kumar, P., Kumar, S. and Kaluza, J. (1996). Increased expression of TGF-b 1 in brain tissue after ischemic stroke in humans. Stroke 27, 852-857.
20. Larrivée, B., Prahst, C., Gordon, E., del Toro, R., Mathivet, T., Duarte, A., Simons, M. and Eichmann, A. (2012). ALK1 signaling inhibits angiogenesis by cooperating with the Notch pathway. Dev. Cell 22, 489-500.
21. Larsson, J., Goumans, M.-J., Sjöstrand, L. J., van Rooijen, M. A., Ward, D., Levéen, P., Xu, X., ten Dijke, P., Mummery, C. L. and Karlsson, S. (2001). Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice. EMBO J. 20, 1663-1673.
22. Lebrin, F., Goumans, M. J., Jonker, L., Carvalho, R. L., Valdimarsdottir, G., Thorikay, M., Mummery, C., Arthur, H. M. and ten Dijke, P. (2004). Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction. EMBO J. 23, 4018-4028.
23. Lebrin, F., Deckers, M., Bertolino, P. and Ten Dijke, P. (2005). TGF-beta receptor function in the endothelium. Cardiovasc. Res. 65, 599-608.
24. Lee, N. Y., Ray, B., How, T. and Blobe, G. C. (2008). Endoglin promotes transforming growth factor beta-mediated Smad 1/5/8 signaling and inhibits endothelial cell migration through its association with GIPC. J. Biol. Chem. 283, 32527-32533.
25. Lee, N. Y., Golzio, C., Gatza, C. E., Sharma, A., Katsanis, N. and Blobe, G. C. (2012). Endoglin regulates PI3-kinase/Akt trafficking and signaling to alter endothelial capillary stability during angiogenesis. Mol. Biol. Cell 23, 2412-2423.
26. Leight, J. L., Wozniak, M. A., Chen, S., Lynch, M. L. and Chen, C. S. (2012). Matrix rigidity regulates a switch between TGF-b1-induced apoptosis and epithelialmesenchymal transition. Mol. Biol. Cell 23, 781-791.
27. Leung, D. W., Cachianes, G., Kuang, W. J., Goeddel, D. V. and Ferrara, N. (1989). Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246, 1306-1309.
28. Li, D. Y., Sorensen, L. K., Brooke, B. S., Urness, L. D., Davis, E. C., Taylor, D. G., Boak, B. B. and Wendel, D. P. (1999). Defective angiogenesis in mice lacking endoglin. Science 284, 1534-1537.
29. Li, C., Hampson, I. N., Hampson, L., Kumar, P., Bernabeu, C., Kumar, S.; LI (2000). CD105 antagonizes the inhibitory signaling of transforming growth factor b1 on human vascular endothelial cells. FASEB J. 14, 55-64.
30. Lu, Q. (2008). Transforming growth factor-b1 protects against pulmonary artery endothelial cell apoptosis via ALK5. Am. J. Physiol. 295, L123-L133.
31. Lund, S. A., Giachelli, C. M. and Scatena, M. (2009). The role of osteopontin in inflammatory processes. J. Cell Commun. Signal 3, 311-322.
32. Lutty, G. A., Merges, C., Threlkeld, A. B., Crone, S. and McLeod, D. S. (1993). Heterogeneity in localization of isoforms of TGF-beta in human retina, vitreous, and choroid. Invest. Ophthalmol. Vis. Sci. 34, 477-487.
33. Mahmoud, M., Allinson, K. R., Zhai, Z., Oakenfull, R., Ghandi, P., Adams, R. H., Fruttiger, M. and Arthur, H. M. (2010). Pathogenesis of arteriovenous malformations in the absence of endoglin. Circ. Res. 106, 1425-1433.
34. Miller, D. W., Graulich, W., Karges, B., Stahl, S., Ernst, M., Ramaswamy, A., Sedlacek, H. H., Müller, R. and Adamkiewicz, J. (1999). Elevated expression of endoglin, a component of the TGF-beta-receptor complex, correlates with proliferation of tumor endothelial cells. Int. J. Cancer 81, 568-572.
35. Mu, Y., Gudey, S. K. and Landström, M. (2012). Non-Smad signaling pathways. Cell Tissue Res. 347, 11-20.
36. Neubauer, K., Krüger, M., Quondamatteo, F., Knittel, T., Saile, B. and Ramadori, G. (1999). Transforming growth factor-beta1 stimulates the synthesis of basement membrane proteins laminin, collagen type IV and entactin in rat liver sinusoidal endothelial cells. J. Hepatol. 31, 692-702.
37. Neufeld, G., Cohen, T., Gengrinovitch, S. and Poltorak, Z. (1999). Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 13, 9-22.
38. Oh, S. P., Seki, T., Goss, K. A., Imamura, T., Yi, Y., Donahoe, P. K., Li, L., Miyazono, K., ten Dijke, P., Kim, S. et al. (2000). Activin receptor-like kinase 1 modulates transforming growth factor-b 1 signaling in the regulation of angiogenesis. Proc. Natl. Acad. Sci. USA 97, 2626-2631.
39. Oshima, M., Oshima, H. and Taketo, M. M. (1996). TGF-b receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis. Dev. Biol. 179, 297-302.
40. Park, S., DiMaio, T. A., Scheef, E. A., Sorenson, C. M. and Sheibani, N. (2010). PECAM-1 regulates proangiogenic properties of endothelial cells through modulation of cell-cell and cell-matrix interactions. Am. J. Physiol. 299, C1468-C1484.
41. Pece-Barbara, N., Vera, S., Kathirkamathamby, K., Liebner, S., Di Guglielmo, G. M., Dejana, E., Wrana, J. L. and Letarte, M. (2005). Endoglin null endothelial cells proliferate faster and are more responsive to transforming growth factor beta1 with higher affinity receptors and an activated Alk1 pathway. J. Biol. Chem. 280, 27800-27808.
42. Pepper, M. S. (1997). Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev. 8, 21-43.
43. Pollman, M. J., Naumovski, L. and Gibbons, G. H. (1999a). Endothelial cell apoptosis in capillary network remodeling. J. Cell. Physiol. 178, 359-370.
44. Pollman, M. J., Naumovski, L. and Gibbons, G. H. (1999b). Vascular cell apoptosis: cell type-specific modulation by transforming growth factor-beta1 in endothelial cells versus smooth muscle cells. Circulation 99, 2019-2026.
45. Ray, B. N., Lee, N. Y., How, T. and Blobe, G. C. (2010). ALK5 phosphorylation of the endoglin cytoplasmic domain regulates Smad1/5/8 signaling and endothelial cell migration. Carcinogenesis 31, 435-441.
46. Rudini, N., Felici, A., Giampietro, C., Lampugnani, M., Corada, M., Swirsding, K., Garrè, M., Liebner, S., Letarte, M., ten Dijke, P. et al. (2008). VE-cadherin is a critical endothelial regulator of TGF-beta signalling. EMBO J. 27, 993-1004.
47. Sabet, M. D. and Gordon, S. R. (1989). Ultrastructural immunocytochemical localization of fibronectin deposition during corneal endothelial wound repair. Evidence for cytoskeletal involvement. Biol. Cell 65, 171-179.
48. Santibanez, J. F., Letamendia, A., Perez-Barriocanal, F., Silvestri, C., Saura, M., Vary, C. P., Lopez-Novoa, J. M., Attisano, L. and Bernabeu, C. (2007). Endoglin increases eNOS expression by modulating Smad2 protein levels and Smad2-dependent TGF-beta signaling. J. Cell. Physiol. 210, 456-468.
49. Seki, T., Yun, J. and Oh, S. P. (2003). Arterial endothelium-specific activin receptorlike kinase 1 expression suggests its role in arterialization and vascular remodeling. Circ. Res. 93, 682-689.
50. Sheibani, N., Sorenson, C. M. and Frazier, W. A. (2000). Differential modulation of cadherin-mediated cell-cell adhesion by platelet endothelial cell adhesion molecule-1 isoforms through activation of extracellular regulated kinases. Mol. Biol. Cell 11, 2793-2802.
51. Smith, L. E., Wesolowski, E., McLellan, A., Kostyk, S. K., D'Amato, R., Sullivan, R. and D'Amore, P. A. (1994). Oxygen-induced retinopathy in the mouse. Invest. Ophthalmol. Vis. Sci. 35, 101-111.
52. Su, X., Sorenson, C. M. and Sheibani, N. (2003). Isolation and characterization of murine retinal endothelial cells. Mol. Vis. 9, 171-178.
53. Tang, Y., Scheef, E. A., Gurel, Z., Sorenson, C. M., Jefcoate, C. R. and Sheibani, N. (2010). CYP1B1 and endothelial nitric oxide synthase combine to sustain proangiogenic functions of endothelial cells under hyperoxic stress. Am. J. Physiol. 298, C665-C678.
54. ten Dijke, P., Goumans, M. J. and Pardali, E. (2008). Endoglin in angiogenesis and vascular diseases. Angiogenesis 11, 79-89.
55. Toporsian, M., Gros, R., Kabir, M. G., Vera, S., Govindaraju, K., Eidelman, D. H., Husain, M. and Letarte, M. (2005). A role for endoglin in coupling eNOS activity and regulating vascular tone revealed in hereditary hemorrhagic telangiectasia. Circ. Res. 96, 684-692.
56. Tucker, R. P. (1991). The distribution of J1/tenascin and its transcript during the development of the avian cornea. Differentiation 48, 59-66.
57. Wang, S., Wu, Z., Sorenson, C. M., Lawler, J. and Sheibani, N. (2003). Thrombospondin-1-deficient mice exhibit increased vascular density during retinal vascular development and are less sensitive to hyperoxia-mediated vessel obliteration. Dev. Dyn. 228, 630-642.
58. Wu, J. and Sheibani, N. (2003). Modulation of VE-cadherin and PECAM-1 mediated cell-cell adhesions by mitogen-activated protein kinases. J. Cell. Biochem. 90, 121-137.